-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
HBV-IN-22
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2338573-94-5.gif)
| Category | Hepatitis B Virus (HBV) |
| CAS | 2338573-94-5 |
| Description | HBV-IN-22 (Compound LC5f) is an inhibitor of HBV DNA replication with IC50 values of 0.71 µM and 0.84 µM against wild-type and drug resistant HBV strains, respectively. |
Product Information
| Synonyms | HBV-IN-22|CHEMBL4555299|BDBM50513194|HY-146394|CS-0498631 |
| Molecular Weight | 479.66 |
| Molecular Formula | C26H29N3O2S2 |
| Canonical SMILES | CCN(CC)CCOC1=CC2=C(C=C1)N=C(N(C2=O)CC3=CC=CS3)SCC4=CC=CC=C4 |
| Purity | ≥98% (HPLC) |
| Solubility | 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 651 |
| Exact Mass | 479.17011952 |
| Target | IC50: 0.71 µM (wild-type HBV DNA replication), 0.84 µM (drug resistant HBV DNA replication) |
| XLogP3-AA | 5.3 |
